Healthcare Industry Today: Adenoviruses News http://health.einnews.com/news/adenovirusesConstantly updated news and information about healthcare industry. FranTech Asia licensing Munogenics, Inc. http://health.einnews.com/news.php?wid=191763254 6 Oct 2008 23:34 GMT ... Sciences, Medical Center ("WFUHS") new cancer treatments technology for research in the field of adenovirus-based gene delivery for cancer treatment. Munogenics has also obtained an option for a non-exclusive ... NanoViricides, Inc. to File Annual Report Shortly; Discusses Status of Current Projects http://health.einnews.com/news.php?wid=191708017 6 Oct 2008 19:19 GMT ... financing, we are now busy scheduling the follow-on studies against HIV as well as adenoviral EKC. We have received significant interest from several major pharmaceutical companies, as well as ... NanoViricides, Inc. to File Annual Report Shortly; Discusses Status of Current Projects Temporary Stock Symbol Change Will Be Reversed http://health.einnews.com/news.php?wid=191707769 6 Oct 2008 19:18 GMT ... financing, we are now busy scheduling the follow-on studies against HIV as well as adenoviral EKC. We have received significant interest from several major pharmaceutical companies, as well as ... Researchers create stem cells that lower risk of cancer-causing side effects http://health.einnews.com/news.php?wid=191698067 6 Oct 2008 18:28 GMT ... the Harvard Stem Cell Institute successfully created mouse-induced pluripotent stem (iPS) cells by using adenoviruses, instead of retroviruses as used in experiments by Professor Shinya Yamanaka at Kyoto University ... --> Crucell Receives NIAID/NIH Contract for Development of Ebola and Marburg Vaccines http://health.einnews.com/news.php?wid=191325265 4 Oct 2008 00:06 GMT ... Goudsmit, Crucell's Chief Scientific Officer. "This award recognizes the scientific basis for using rare adenovirus serotypes to develop vaccines." Dr. Goudsmit added, "The contract builds upon earlier work Crucell ... Crucell Receives NIAID/NIH Contract for Development of Ebola and Marburg Vaccines http://health.einnews.com/news.php?wid=191322839 3 Oct 2008 23:36 GMT ... Goudsmit, Crucell's Chief Scientific Officer. "This award recognizes the scientific basis for using rare adenovirus serotypes to develop vaccines." Dr. Goudsmit added, "The contract builds upon earlier work Crucell ... Losing common ground http://health.einnews.com/news.php?wid=191258455 3 Oct 2008 06:55 GMT ... have actually increased HIV susceptibility among some subjects. The problem may have been the adenovirus (common cold virus) used to deliver the candidate vaccine, since everyones immune system responds ... NIAID Renews HIV Vaccine Contract with GenVec for $3.8M http://health.einnews.com/news.php?wid=191206120 3 Oct 2008 00:56 GMT ... the development of new HIV vaccine candidates, which are based on multiple serotypes of adenovirus. GenVec's adenovector technology platform now includes six distinct serotypes that can be used singly ...